363 related articles for article (PubMed ID: 27380775)
61. SC35 and heterogeneous nuclear ribonucleoprotein A/B proteins bind to a juxtaposed exonic splicing enhancer/exonic splicing silencer element to regulate HIV-1 tat exon 2 splicing.
Zahler AM; Damgaard CK; Kjems J; Caputi M
J Biol Chem; 2004 Mar; 279(11):10077-84. PubMed ID: 14703516
[TBL] [Abstract][Full Text] [Related]
62. Intron sequences and the length of the downstream second exon affect the binding of hnRNP C proteins in an in vitro splicing reaction.
Goswami P; Goldenberg CJ
Nucleic Acids Res; 1988 Jun; 16(11):4995-5011. PubMed ID: 3290845
[TBL] [Abstract][Full Text] [Related]
63. Control of 3' splice site choice in vivo by ASF/SF2 and hnRNP A1.
Bai Y; Lee D; Yu T; Chasin LA
Nucleic Acids Res; 1999 Feb; 27(4):1126-34. PubMed ID: 9927747
[TBL] [Abstract][Full Text] [Related]
64. A truncated hnRNP A1 isoform, lacking the RGG-box RNA binding domain, can efficiently regulate HIV-1 splicing and replication.
Jean-Philippe J; Paz S; Lu ML; Caputi M
Biochim Biophys Acta; 2014; 1839(4):251-8. PubMed ID: 24530421
[TBL] [Abstract][Full Text] [Related]
65. Differential hnRNP D isoform incorporation may confer plasticity to the ESSV-mediated repressive state across HIV-1 exon 3.
Hillebrand F; Peter JO; Brillen AL; Otte M; Schaal H; Erkelenz S
Biochim Biophys Acta Gene Regul Mech; 2017 Feb; 1860(2):205-217. PubMed ID: 27919832
[TBL] [Abstract][Full Text] [Related]
66. Heterogeneous nuclear ribonucleoprotein (hnRNP) K is a component of an intronic splicing enhancer complex that activates the splicing of the alternative exon 6A from chicken beta-tropomyosin pre-mRNA.
Expert-Bezançon A; Le Caer JP; Marie J
J Biol Chem; 2002 May; 277(19):16614-23. PubMed ID: 11867641
[TBL] [Abstract][Full Text] [Related]
67. Identification of a 17-nucleotide splicing enhancer in HPV-16 L1 that counteracts the effect of multiple hnRNP A1-binding splicing silencers.
Zhao X; Fay J; Lambkin H; Schwartz S
Virology; 2007 Dec; 369(2):351-63. PubMed ID: 17869320
[TBL] [Abstract][Full Text] [Related]
68. Solution Structure of the HIV-1 Intron Splicing Silencer and Its Interactions with the UP1 Domain of Heterogeneous Nuclear Ribonucleoprotein (hnRNP) A1.
Jain N; Morgan CE; Rife BD; Salemi M; Tolbert BS
J Biol Chem; 2016 Jan; 291(5):2331-44. PubMed ID: 26607354
[TBL] [Abstract][Full Text] [Related]
69. Heterogeneous ribonucleoprotein A1 is part of an exon-specific splice-silencing complex controlled by oncogenic signaling pathways.
Matter N; Marx M; Weg-Remers S; Ponta H; Herrlich P; König H
J Biol Chem; 2000 Nov; 275(45):35353-60. PubMed ID: 10958793
[TBL] [Abstract][Full Text] [Related]
70. Recombinant hnRNP protein A1 and its N-terminal domain show preferential affinity for oligodeoxynucleotides homologous to intron/exon acceptor sites.
Buvoli M; Cobianchi F; Biamonti G; Riva S
Nucleic Acids Res; 1990 Nov; 18(22):6595-600. PubMed ID: 2251120
[TBL] [Abstract][Full Text] [Related]
71. Position-dependent splicing activation and repression by SR and hnRNP proteins rely on common mechanisms.
Erkelenz S; Mueller WF; Evans MS; Busch A; Schöneweis K; Hertel KJ; Schaal H
RNA; 2013 Jan; 19(1):96-102. PubMed ID: 23175589
[TBL] [Abstract][Full Text] [Related]
72. Determination of the RNA binding specificity of the heterogeneous nuclear ribonucleoprotein (hnRNP) H/H'/F/2H9 family.
Caputi M; Zahler AM
J Biol Chem; 2001 Nov; 276(47):43850-9. PubMed ID: 11571276
[TBL] [Abstract][Full Text] [Related]
73. The c.5242C>A BRCA1 missense variant induces exon skipping by increasing splicing repressors binding.
Millevoi S; Bernat S; Telly D; Fouque F; Gladieff L; Favre G; Vagner S; Toulas C
Breast Cancer Res Treat; 2010 Apr; 120(2):391-9. PubMed ID: 19404736
[TBL] [Abstract][Full Text] [Related]
74. TDP-43 regulates the alternative splicing of hnRNP A1 to yield an aggregation-prone variant in amyotrophic lateral sclerosis.
Deshaies JE; Shkreta L; Moszczynski AJ; Sidibé H; Semmler S; Fouillen A; Bennett ER; Bekenstein U; Destroismaisons L; Toutant J; Delmotte Q; Volkening K; Stabile S; Aulas A; Khalfallah Y; Soreq H; Nanci A; Strong MJ; Chabot B; Vande Velde C
Brain; 2018 May; 141(5):1320-1333. PubMed ID: 29562314
[TBL] [Abstract][Full Text] [Related]
75. An exon skipping-associated nonsense mutation in the dystrophin gene uncovers a complex interplay between multiple antagonistic splicing elements.
Disset A; Bourgeois CF; Benmalek N; Claustres M; Stevenin J; Tuffery-Giraud S
Hum Mol Genet; 2006 Mar; 15(6):999-1013. PubMed ID: 16461336
[TBL] [Abstract][Full Text] [Related]
76. VERSE: a varying effect regression for splicing elements discovery.
Zhang J; Kuo CC; Chen L
J Comput Biol; 2012 Jun; 19(6):855-65. PubMed ID: 22651811
[TBL] [Abstract][Full Text] [Related]
77. Intronic PAH gene mutations cause a splicing defect by a novel mechanism involving U1snRNP binding downstream of the 5' splice site.
Martínez-Pizarro A; Dembic M; Pérez B; Andresen BS; Desviat LR
PLoS Genet; 2018 Apr; 14(4):e1007360. PubMed ID: 29684050
[TBL] [Abstract][Full Text] [Related]
78. Solution structure of the HIV-1 exon splicing silencer 3.
Levengood JD; Rollins C; Mishler CH; Johnson CA; Miner G; Rajan P; Znosko BM; Tolbert BS
J Mol Biol; 2012 Jan; 415(4):680-98. PubMed ID: 22154809
[TBL] [Abstract][Full Text] [Related]
79. Rules of RNA specificity of hnRNP A1 revealed by global and quantitative analysis of its affinity distribution.
Jain N; Lin HC; Morgan CE; Harris ME; Tolbert BS
Proc Natl Acad Sci U S A; 2017 Feb; 114(9):2206-2211. PubMed ID: 28193894
[TBL] [Abstract][Full Text] [Related]
80. Pseudoexon activation in disease by non-splice site deep intronic sequence variation - wild type pseudoexons constitute high-risk sites in the human genome.
Petersen USS; Doktor TK; Andresen BS
Hum Mutat; 2022 Feb; 43(2):103-127. PubMed ID: 34837434
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
